Skip to main content
SpringerLink
Log in

Pentoxifylline and naftidrofuryl: commonly used drugs for intermittent claudication

  • New Drugs and Therapeutic
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Creager MA, Dzau VJ. Vascular diseases of the extremities. In: Isselbacher KJ, et al., editors. Harrison’s principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994; 1135–7

    Google Scholar 

  2. Bevan EG, Waller PC, Ramsay LE. Pharmacological approaches to the treatment of intermittent claudication. Drugs Aging 1992 Mar–Apr; 2: 125–363.

    Article  PubMed  CAS  Google Scholar 

  3. Radack K, Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med 1990 Jul 15; 113: 135–46

    PubMed  CAS  Google Scholar 

  4. Martindale. The Extra Pharmacopoeia, 30th ed. London: Pharmaceutical Press, 1993: 1308–13

    Google Scholar 

  5. Frampton JE, Brogden RN. Pentoxifylline (oxypentifylline): a review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders. Drug Aging 1995 Dec; 7(6): 480–503

    Article  CAS  Google Scholar 

  6. Barradell LB, Brogden RN. Oral naftidrofuryl: a review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease. Drug Aging 1996 Apr; 8(4): 299–322

    Article  CAS  Google Scholar 

  7. Gillings D, Koch G, Reich T, et al. Another look at the pentoxifylline efficacy data for intermittent claudication. J Clin Pharmacol 1987 Aug; 27: 601–9

    PubMed  CAS  Google Scholar 

  8. Lindgärde F, Jelnes R, Björkman H, et al. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group. Circulation 1989 Dec; 80: 1549–56

    Article  PubMed  Google Scholar 

  9. Ernst E, Kollár L, Resch KL. Does pentoxifylline prolong the walking distance in exercised claudicants? A placebo-controlled double-blind trial. Angiology 1992 Feb; 43: 121–5

    Article  PubMed  CAS  Google Scholar 

  10. Adhoute G, Bacourt F, Barrai M, et al. Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using Naftidrofuryl tablets 200 mg. Angiology 1986 Mar; 37 (3 Pt 1): 160–7

    Article  PubMed  CAS  Google Scholar 

  11. Kriessmann A, Neiss A. Clinical effectiveness of naftidrofuryl in intermittent claudication [in German]. Vasa Suppl 1988; 24: 27–32

    PubMed  CAS  Google Scholar 

  12. Trübestein G, Böhme H, Heidrich H, et al. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study. Angiology 1984 Nov; 35: 701–8

    Article  PubMed  Google Scholar 

  13. Adhoute G, Andreassian B, Boccalon H, et al. Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multi-center study. J Cardiovasc Pharmacol 1990; 16 Suppl. 3: S75–80

    PubMed  Google Scholar 

  14. Clyne CAC, Galland RB, Fox MJ, et al. A controlled trial of naftidrofuryl (Praxilene) in the treatment of intermittent claudication. Br J Surg 1980 May; 67: 347–8

    Article  PubMed  CAS  Google Scholar 

  15. Cameron HA, Waller PC, Ramsay LE. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965–1985. Br J Clin Pharmacol 1988 Nov; 26: 569–76

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pentoxifylline and naftidrofuryl: commonly used drugs for intermittent claudication. Drugs Ther. Perspect 7, 1–5 (1996). https://doi.org/10.2165/00042310-199607100-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607100-00001

Search

Navigation